Timothy J Hoffman Selected Research

Timothy J Hoffman Research Topics

Disease

37	Neoplasms (Cancer) 02/2015 - 03/2002
11	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 02/2003
5	Melanoma (Melanoma, Malignant) 07/2009 - 10/2002
5	Colonic Neoplasms (Colon Cancer) 09/2006 - 03/2002
4	Colorectal Neoplasms (Colorectal Cancer) 07/2010 - 07/2006
4	Breast Neoplasms (Breast Cancer) 01/2010 - 07/2006
2	Atherosclerosis 07/2023 - 02/2023
2	Glioblastoma (Glioblastoma Multiforme) 02/2015 - 02/2014
2	Neoplasm Metastasis (Metastasis) 06/2013 - 12/2012
2	Carcinoma (Carcinomatosis) 01/2010 - 03/2006
2	Pancreatic Neoplasms (Pancreatic Cancer) 05/2007 - 05/2003
1	Lymphatic Metastasis 06/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2008
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 04/2006
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2006

Drug/Important Bio-Agent (IBA)

23	Peptides (Polypeptides)IBA 02/2015 - 10/2002
14	Bombesin Receptors (Bombesin Receptor)IBA 02/2015 - 05/2003
11	BombesinIBA 02/2015 - 05/2003
10	RadiopharmaceuticalsIBA 02/2015 - 03/2002
9	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2015 - 03/2002
5	LigandsIBA 02/2015 - 07/2007
5	AcidsIBA 04/2014 - 05/2008
5	Enterotoxins (Enterotoxin)IBA 07/2010 - 05/2006
5	Gastrin-Releasing PeptideIBA 01/2010 - 05/2003
5	alpha-MSHIBA 07/2009 - 10/2002
4	triazacyclononaneIBA 04/2014 - 02/2009
4	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2014 - 07/2007
4	Enterotoxin ReceptorsIBA 07/2010 - 03/2002
3	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 04/2014 - 10/2010
3	Guanylate Cyclase (Guanylyl Cyclase)IBA 07/2010 - 05/2006
3	Radioisotopes (Radionuclides)IBA 09/2007 - 01/2005
2	CXCR3 ReceptorsIBA 07/2023 - 02/2023
2	Fluorine-18IBA 07/2023 - 02/2023
2	IntegrinsIBA 02/2015 - 02/2014
2	Copper-64IBA 04/2014 - 10/2010
2	leucylmethionineIBA 04/2012 - 07/2003
2	glycylhistidineIBA 04/2012 - 07/2003
2	Chelating AgentsIBA 07/2010 - 03/2005
2	uroguanylinIBA 10/2009 - 05/2006
2	heat stable toxin (E coli)IBA 09/2006 - 05/2006
2	AndrogensIBA 04/2006 - 05/2003
1	GoldIBA 08/2014
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 04/2014
1	Biomarkers (Surrogate Marker)IBA 04/2014
1	AntigensIBA 04/2014
1	5-aminovaleric acidIBA 04/2014
1	Glutamic Acid (Glutamate)FDA Link 04/2012
1	arginyl-glycyl-aspartic acidIBA 04/2012
1	4-Aminobenzoic Acid (4 Aminobenzoic Acid)IBA 10/2010
1	beta-AlanineIBA 10/2010
1	bombesin (7-14)IBA 01/2010
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2009
1	RheniumIBA 07/2009
1	(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)IBA 02/2009
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2008
1	(4,11- bis(carboxymethyl)- 1,4,8,11- tetraazabicyclo(6.6.2)hexadecane)copper(II)IBA 08/2007
1	Fluorescent Dyes (Fluorescent Probes)IBA 05/2007
1	RNA (Ribonucleic Acid)IBA 07/2006
1	guanylinIBA 07/2006
1	Carrier Proteins (Binding Protein)IBA 07/2006
1	Estrogen ReceptorsIBA 07/2006
1	Glucose (Dextrose)FDA LinkGeneric 04/2006
1	VA 061 (VA061)IBA 04/2006
1	Monoclonal AntibodiesIBA 03/2006
1	Insulin (Novolin)FDA Link 01/2006
1	MetalsIBA 03/2005
1	Therapeutic UsesIBA 01/2005
1	IndiumIBA 07/2004
1	2,3-diaminopropionic acidIBA 07/2003
1	HydrocarbonsIBA 05/2003
1	CarbonIBA 05/2003
1	Amino Acids FDA Link 10/2002
1	Lysine (L-Lysine)FDA Link 10/2002
1	DisulfidesIBA 03/2002

Therapy/Procedure

9	Therapeutics 02/2015 - 10/2002
4	Radiotherapy 02/2014 - 10/2002
2	Intravenous Injections 02/2015 - 02/2014
2	Drug Therapy (Chemotherapy) 09/2008 - 04/2006
1	Radioimmunotherapy 03/2006
1	Aftercare (After-Treatment) 01/2005